Cancers 2014, 6(1), 416-435; doi:10.3390/cancers6010416

Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression

1,2email, 2email and 2,* email
Received: 25 December 2013; in revised form: 7 February 2014 / Accepted: 8 February 2014 / Published: 17 February 2014
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a zinc-dependent type-I transmembrane metalloproteinase involved in pericellular proteolysis, migration and invasion. Numerous substrates and binding partners have been identified for MT1-MMP, and its role in collagenolysis appears crucial for tumor invasion. However, development of MT1-MMP inhibitors must consider the substantial functions of MT1-MMP in normal physiology and disease prevention. The present review examines the plethora of MT1-MMP activities, how these activities relate to cancer initiation and progression, and how they can be monitored in real time. Examination of MT1-MMP activities and cell surface behaviors can set the stage for the development of unique, selective MT1-MMP inhibitors.
Keywords: MT1-MMP; MMP-14; matrix metalloproteinases; CD44; collagen; metastasis
PDF Full-text Download PDF Full-Text [1017 KB, uploaded 17 February 2014 09:05 CET]

Export to BibTeX |

MDPI and ACS Style

Pahwa, S.; Stawikowski, M.J.; Fields, G.B. Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression. Cancers 2014, 6, 416-435.

AMA Style

Pahwa S, Stawikowski MJ, Fields GB. Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression. Cancers. 2014; 6(1):416-435.

Chicago/Turabian Style

Pahwa, Sonia; Stawikowski, Maciej J.; Fields, Gregg B. 2014. "Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression." Cancers 6, no. 1: 416-435.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert